Leading swine veterinarians address overall vaccination compliance issues critical to effectively managing Mycoplasma hyopneumoniae and porcine circovirus in the latest At the Meeting (ATM) programme, produced by Dr Bob Morrison, University of Minnesota.
CHINA & GERMANY
Research driven pharmaceutical company Boehringer Ingelheim, in partnership with Taizhou China Medical City in Jiangsu Province, China, held a ground-breaking ceremony for a veterinary vaccine manufacturing plant at the China Medical City (Taizhou China Medicine High-Tech Development Zone) last week (Friday, 16 August).
US - Controlling swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCV2) and Mycoplasma pneumonia (M. hyo) is one of the the key challenges for producers and veterinarians. During the 2012 World Pork Expo, swine experts discussed the impacts of these diseases, the latest research and effective ways to manage respiratory diseases on modern production farms.
US - The research driven pharmaceutical company Boehringer Ingelheim will expand its global animal health vaccines business. With the completion of a series of major investments at the US site in St. Joseph, Missouri, the company will further enhance its position in the development and supply of vaccines against the most important diseases of pigs.
US - A mystery virus that has been causing tremors in piglets for decades has now been pinpointed by a team of veterinary researchers from Iowa State University. The virus, which comes from a family known as ‘pestiviruses,’ infects young pigs and can cause them to shake involuntarily.
Boehringer Ingelheim provides three €25,000 grants to fund independent research projects that generate new and practical information to allow a better understanding of this devastating swine disease PRRS (Porcine Reproductive and Respiratory Syndrome).
Boehringer Ingelheim’s market leading Animal Health medication Metacam® (active ingredient: Meloxicam) obtained EU wide marketing authorisation as an oral suspension in a concentration of 15 mg/ml for use in pigs.
Get the latest news on Swine Health Subscribe to our newsletter